Maria Belvisi

SVP & Head of Respiratory Research and Early Development BioPharmaceuticals R&D AstraZeneca & Prof Respiratory Pharmacology. Imperial College

[Maria Belvisi @MariaBelvisi4]

Bonvini and co-workers employ a creative combination of cell, tissue and in vivo models to delineate a complex intercellular communication between mast cells and airway smooth muscle by which TRPV4 activation causes bronchoconstriction https://t.co/aSksxJ91MS

[Maria Belvisi @MariaBelvisi4]

Read about how ⁦⁦⁦@AstraZeneca⁩ are participating in collaborations to treat COVID-19 patients #covid-19 #research #proudpartner #joiningforces https://t.co/RhdgFMyrfC

[Maria Belvisi @MariaBelvisi4]

@ruth_march @AstraZeneca @acmedsci I will come to celebrate with you afterwards @ruth_march

[Maria Belvisi @MariaBelvisi4]

⁦@MariaBelvisi4⁩ @TimEisen attended the ⁦@acmedsci⁩ ceremony for new fellows yesterday. Great honour to be elected.

[Maria Belvisi @MariaBelvisi4]

⁦@QueensTennis⁩

[Maria Belvisi @MariaBelvisi4]

@ruth_march @AstraZeneca @MenePangalos @priestleycc1 @AstraZenecaJobs Glad you were there @ruth_march

[Maria Belvisi @MariaBelvisi4]

@stuartacook1 @MenePangalos @AstraZeneca Hi, already on it. have seen your cardiovascular fibrosis nature paper and recent work in IPF. Good to catch up?

[Prof Sir Mene Pangalos FRS @MenePangalos]

Very excited to have Peter joining us a Chief Scientist in our Respiratory group @MariaBelvisi4 @AstraZeneca

[Maria Belvisi @MariaBelvisi4]

@MenePangalos @AstraZeneca Great to be working closely again with Peter Barnes FRS.

[trppapers @trp_papers]

Allergen challenge increases capsaicin evoked cough responses in allergic asthma. https://t.co/6lrN7w7HJw

[Maria Belvisi @MariaBelvisi4]

@MenePangalos @AstraZeneca @WomenScience Second that. Amazing achievements and an inspiration to all of us

[Maria Belvisi @MariaBelvisi4]

@MenePangalos @AstraZeneca Grateful to have the opportunity and mentorship to address the unmet need in chronic lung disease. Thanks to @MenePangalos

[AstraZeneca @AstraZeneca]

To reach our goal of modifying & ultimately curing #respiratory disease, we need to be able to address targets previously seen as inaccessible. @MariaBelvisi4, Vice President and Head, RIA Innovative Medicines, explains how we're doing this: https://t.co/KUapAncu9B. #ERSCongress

[AstraZeneca @AstraZeneca]

Our aim is to achieve respiratory disease modification & cure. To unlock new pathways, we are exploring advancements in #biotechnology. We believe that drug modalities like oligonucleotides allow us to target the underlying causes of #asthma. https://t.co/6Yn543QIZq #ERSCongress

[Maria Belvisi @MariaBelvisi4]

Exciting times!

[AstraZeneca @AstraZeneca]

Our aim is to achieve respiratory disease modification & cure. To unlock new pathways, we are exploring advancements in #biotechnology. We believe that drug modalities like oligonucleotides allow us to target the underlying causes of #asthma. https://t.co/6Yn543QIZq #ERSCongress

[British Pharmacological Society @BritPharmSoc]

One week left to register for Current trends in drug discovery (7 June). Hear 3 internationally recognised speakers – including @MariaBelvisi4 of @AstraZeneca talk abouton discovering new therapeutic options for chronic respiratory disease. https://t.co/iHScbhN3lq

[Maria Belvisi @MariaBelvisi4]

Sad day..Tessa Jowell RIP. https://t.co/iPfpnsQTEj

[Nick Hopkinson @COPDdoc]

Respect. Tessa Jowell was the UK’s first Minister of Public Health - a passionate campaigner on smoking and responsible for Smoking Kills (1998), the first Gov't White Paper specifically on smoking. https://t.co/TnfoPTeWjk

[john williams @wi_john]

Sir Mark Walport said British and EU scientists should be able to live and work freely across Europe. “In any good lab you will find researchers from all over the world,” https://t.co/DHMDxkwFzO

[Maria Belvisi @MariaBelvisi4]

#RotterdamOpen #abnamrowwtt #worldnumber1
#KingRoger

[NHLI @ImperialNHLI]

. @imperialcollege partners with AstraZeneca to investigate drivers of #respiratory disease https://t.co/Pn1Rw9RkDN - with Profs Belvisi & Tetley and Dr Birrell.